ESSA Pharma Inc.
NASDAQ:EPIX
Overview | Financials
Company Name | ESSA Pharma Inc. |
Symbol | EPIX |
Currency | USD |
Price | 1.76 |
Market Cap | 78,089,366 |
Dividend Yield | 0% |
52-week-range | 1.4 - 11.67 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. David Ross Parkinson M.D. |
Website | https://www.essapharma.com |
An error occurred while fetching data.
About ESSA Pharma Inc.
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD